Live attenuated vaccine · VDDBV0670
Note: 1 additional source trial listed this vaccine in studies of unrelated viruses (e.g. as a comparator, adjunct, or in coadministration trials with other vaccines). Those trials are not shown here.
| NCT ID | Phase | Disease / Condition |
|---|---|---|
| NCT02788227 | Phase 2 | Ebola Virus Disease |
| NCT02378753 | Phase 3 | Ebola Virus Disease |
| NCT03161366 | Phase 3 | Ebola Virus Disease |
| NCT05130398 | Phase 2 | Ebola Virus Disease |
| NCT02283099 | Phase 1 | Ebola Virus Disease |
| NCT03031912 | Phase 2 | Ebola Virus Disease |
| NCT02314923 | Phase 1 | Ebola Virus Disease |
| NCT02269423 | Phase 1 | Ebola Virus Disease |